While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE...
While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE +7.2%) product announcement, smaller rival Complete Genomics' (GNOM -19.9%) bloodletting worsens as the day progresses. On Monday, the company announced it delivered 300 fewer genomes in Q4 than previously expected, news that triggered a downgrade from Oppenheimer.
From other sites
at 4-traders.com (Mon, 3:48PM)
at Zacks.com (Mon, 8:50AM)
at 4-traders.com (Mon, 8:23AM)
Illumina : Presolicitation Notice - Whole-genome/exome/transcriptome sequencing of metastatic tumors using Illumina'sat 4-traders.com (Mon, 8:23AM)
at 4-traders.com (Mar 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs